DVA Insider Trading
DAVITA INC. | Services-Misc Health & Allied Services, NEC
Comprehensive Trading Performance Summary
The investment history of corporate insiders at DAVITA INC. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Services-Misc Health & Allied Services, NEC sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2020-06-11 01:21 | 2020-06-08 | BERG CHARLES | Director | OPT+S | $87.53 | 357 | $31,249 | 11,004 | 0.0% |
| 2020-06-11 01:21 | 2020-06-08 | ROPER WILLIAM L | Director | OPT+S | $86.79 | 357 | $30,983 | 15,961 | 0.0% |
| 2020-06-11 01:21 | 2020-06-08 | Arway Pamela M | Director | OPT+S | $87.32 | 357 | $31,174 | 19,239 | 0.0% |
| 2020-05-27 23:05 | 2020-05-22 | Arway Pamela M | Director | SELL | $78.90 | 599 | $47,261 | 19,239 | -3.0% |
| 2020-05-20 04:19 | 2020-05-18 | DIAZ PAUL J | Director | SELL | $82.22 | 5,763 | $473,825 | 9,986 | -36.6% |
| 2020-05-14 03:47 | 2020-05-11 | THIRY KENT J | Director, Officer - Executive Chairman | OPT+S | $81.09 | 129,390 | $10,491,925 | 548,653 | 0.0% |
| 2020-03-25 01:42 | 2020-03-20 | Arway Pamela M | Director | SELL | $71.25 | 625 | $44,531 | 19,239 | -3.1% |
| 2020-03-05 03:11 | 2020-03-02 | NEHRA JOHN M | Director | SELL | $80.74 | 7,694 | $621,214 | 54,759 | -12.3% |
| 2020-02-29 03:07 | 2020-02-26 | NEHRA JOHN M | Director | SELL | $80.77 | 31,806 | $2,568,866 | 62,453 | -33.7% |
| 2018-06-12 01:43 | 2018-06-07 | Arway Pamela M | Director | OPT+S | $68.76 | 1,264 | $86,918 | 15,235 | 0.0% |
| 2018-05-25 01:52 | 2018-05-22 | ROPER WILLIAM L | Director | OPT+S | $68.22 | 1,505 | $102,677 | 10,733 | 0.0% |
| 2018-05-17 03:35 | 2018-05-14 | BERG CHARLES | Director | OPT+S | $66.25 | 338 | $22,393 | 5,776 | 0.0% |
| 2018-01-19 03:14 | 2018-01-16 | HILGER JAMES K | Officer - Chief Accounting Officer | OPT+S | $78.95 | 3,572 | $282,008 | 19,649 | 0.0% |
| 2017-12-14 02:09 | 2017-12-11 | BERG CHARLES | Director, Officer - Executive Chair, DMG | SELL | $69.24 | 7,048 | $488,016 | 7,047 | -50.0% |
| 2017-12-13 04:19 | 2017-12-08 | THIRY KENT J | Director, Officer - Chairman and CEO | OPT+S | $68.04 | 81,800 | $5,565,917 | 93,952 | 0.0% |
| 2017-12-13 03:57 | 2017-12-08 | ZUMWALT LEANNE M | Officer - Grp VP, Purch & Public Affairs | OPT+S | $68.19 | 949 | $64,711 | 7,023 | 0.0% |
| 2017-12-12 02:44 | 2017-12-07 | Rodriguez Javier | Officer - Chief Executive Officer, DKC | OPT+S | $67.48 | 22,532 | $1,520,466 | 97,817 | 0.0% |
| 2017-12-12 02:43 | 2017-12-07 | HILGER JAMES K | Officer - Chief Accounting Officer | OPT+S | $69.46 | 5,608 | $389,506 | 19,649 | 0.0% |
| 2017-06-16 00:59 | 2017-06-13 | JIGANTI JEANINE MARIE | Officer - Chief Compliance Officer | OPT+S | $65.57 | 1,886 | $123,665 | 3,514 | 0.0% |
| 2017-05-18 01:59 | 2017-05-15 | Rodriguez Javier | Officer - CEO-Kidney Care | SELL | $66.21 | 1,294 | $85,670 | 97,817 | -1.3% |
| 2017-05-18 00:24 | 2017-05-15 | ZUMWALT LEANNE M | Officer - Grp VP, Purch & Public Affairs | SELL | $66.32 | 1,800 | $119,378 | 7,023 | -20.4% |
| 2017-05-18 00:23 | 2017-05-15 | JIGANTI JEANINE MARIE | Officer - Chief Compliance Officer | SELL | $66.07 | 540 | $35,678 | 3,514 | -13.3% |
| 2017-05-18 00:22 | 2017-05-15 | HILGER JAMES K | Officer - Chief Accounting Officer | SELL | $66.05 | 900 | $59,445 | 16,605 | -5.1% |
| 2017-05-12 01:20 | 2017-05-09 | BERG CHARLES | Director | OPT+S | $65.80 | 8,414 | $553,607 | 10,719 | 0.0% |
| 2017-05-08 21:58 | 2017-05-04 | Valine Roger | Director | OPT+S | $66.21 | 12,994 | $860,367 | 0 | 0.0% |
| 2017-05-08 21:55 | 2017-05-04 | ROPER WILLIAM L | Director | OPT+S | $65.89 | 12,994 | $856,147 | 9,277 | 0.0% |
| 2017-02-28 02:16 | 2017-02-23 | ZUMWALT LEANNE M | Officer - Grp VP, Purch & Public Affairs | SELL | $68.72 | 807 | $55,461 | 0 | -100.0% |
| 2016-08-12 01:38 | 2016-08-09 | STAFFIERI MICHAEL DAVID | Officer - COO, Kidney Care | OPT+S | $73.09 | 20,262 | $1,480,893 | 12,279 | 0.0% |
| 2016-07-13 20:15 | 2016-07-11 | JIGANTI JEANINE MARIE | Officer - Chief Compliance Officer | OPT+S | $78.51 | 1,291 | $101,360 | 3,840 | 0.0% |
| 2016-07-05 22:07 | 2016-07-01 | JIGANTI JEANINE MARIE | Officer - Chief Compliance Officer | OPT+S | $77.45 | 4,620 | $357,834 | 4,778 | 0.0% |
| 2016-05-27 01:18 | 2016-05-25 | Arway Pamela M | Director | OPT+S | $77.16 | 10,824 | $835,216 | 12,394 | 0.0% |
| 2016-05-25 02:18 | 2016-05-23 | HILGER JAMES K | Officer - Interim CFO and CAO | OPT+S | $76.79 | 3,416 | $262,309 | 17,147 | 0.0% |
| 2016-05-25 02:15 | 2016-05-20 | THIRY KENT J | Director, Officer - Chairman and CEO | SELL | $76.99 | 32,880 | $2,531,579 | 39,184 | -45.6% |
| 2016-05-20 00:20 | 2016-05-17 | Kogod Dennis | Officer - Pres, HCP & CEO, DVA Int. | SELL | $77.35 | 17,700 | $1,369,116 | 18,766 | -48.5% |
| 2016-05-20 00:19 | 2016-05-17 | ZUMWALT LEANNE M | Officer - Grp VP, Purch & Public Affairs | SELL | $77.08 | 538 | $41,469 | 8,585 | -5.9% |
| 2016-05-18 01:43 | 2016-05-16 | HILGER JAMES K | Officer - Interim CFO and CAO | SELL | $75.59 | 3,983 | $301,073 | 17,147 | -18.8% |
| 2016-05-18 01:40 | 2016-05-16 | STAFFIERI MICHAEL DAVID | Officer - COO, Kidney Care | SELL | $75.69 | 4,934 | $373,447 | 12,279 | -28.7% |
| 2016-05-18 01:34 | 2016-05-16 | Rodriguez Javier | Officer - CEO-Kidney Care | SELL | $75.44 | 36,466 | $2,751,093 | 64,264 | -36.2% |
| 2016-05-14 01:03 | 2016-05-12 | Valine Roger | Director | OPT+S | $76.34 | 8,220 | $627,534 | 324 | 0.0% |
| 2016-05-12 01:36 | 2016-05-10 | Kogod Dennis | Officer - Pres, HCP & CEO, DVA Int. | OPT+S | $76.25 | 40,048 | $3,053,660 | 36,466 | 0.0% |
| 2016-05-11 01:56 | 2016-05-06 | NEHRA JOHN M | Director | OPT+S | $75.56 | 16,314 | $1,232,761 | 665 | 0.0% |
| 2016-04-12 23:54 | 2016-04-11 | Rodriguez Javier | Officer - CEO-Kidney Care | OPT+S | $73.51 | 89,912 | $6,609,098 | 100,730 | 0.0% |
| 2016-03-23 20:29 | 2016-03-21 | Kogod Dennis | Officer - Pres, HCP & CEO, DVA Int. | OPT+S | $72.12 | 13,455 | $970,317 | 36,466 | 0.0% |
| 2016-03-04 00:18 | 2016-03-02 | STAFFIERI MICHAEL DAVID | Officer - Chief Operating Office, KC | OPT+S | $67.97 | 15,660 | $1,064,346 | 16,833 | 0.0% |
| 2016-03-01 23:58 | 2016-02-29 | Arway Pamela M | Director | OPT+S | $66.00 | 9,026 | $595,716 | 12,070 | 0.0% |
| 2016-02-26 00:05 | 2016-02-23 | ZUMWALT LEANNE M | Officer - Grp VP, Purch & Public Affairs | OPT+S | $64.25 | 14,587 | $937,266 | 9,068 | 0.0% |
| 2016-02-18 22:47 | 2016-02-16 | Kogod Dennis | Officer - Pres, HCP & CEO, DVA Int. | OPT+S | $61.99 | 33,290 | $2,063,674 | 120,816 | 0.0% |
| 2015-12-22 04:41 | 2015-12-17 | Mildenberger Laura | Officer - Chief People Officer | OPT+S | $68.14 | 1,440 | $98,115 | 8,447 | 0.0% |
| 2015-11-13 01:53 | 2015-11-09 | THIRY KENT J | Director, Officer - Chairman and CEO | OPT+S | $75.61 | 300,000 | $22,681,560 | 138,980 | 0.0% |
| 2015-09-25 04:35 | 2015-09-22 | Rivera Kim M | Officer - Chief Legal Officer | OPT+S | $75.48 | 40,037 | $3,022,037 | 7,438 | 0.0% |
How to Interpret $DVA Trades
Not every insider transaction in DAVITA INC. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $DVA shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for DVA
Insider activity data for DAVITA INC. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $DVA, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.